Roche Deutschland Holding GmbH

Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8) (2022) Hahn A, Günther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, et al. Journal article, Erratum Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (2022) Hahn A, Guenther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, et al. Journal article Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues (2021) Friedrich C, Taggenbrock RLRE, Doucet-Ladeveze R, Golda G, Moenius R, Arampatzi P, Kragten NAM, et al. Journal article Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS (2021) Gutzmer R, Schulze HJ, Hauschild A, Leiter U, Meier F, Haferkamp S, Ulrich C, et al. Journal article Deep Learning-based Propensity Scores for Confounding Control in Comparative Effectiveness Research: A Large-scale, Real-world Data Study (2021) Weberpals J, Becker T, Davies J, Schmich F, Ruettinger D, Theis FJ, Bauer-Mehren A Journal article Seamless Virtual Whole Slide Image Synthesis and Validation Using Perceptual Embedding Consistency (2021) Lahiani A, Klaman I, Navab N, Albarqouni S, Klaiman E Journal article The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models (2020) Maser IP, Hoves S, Bayer C, Heidkamp G, Nimmerjahn F, Eckmann J, Ries CH Journal article Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib-results from a non-interventional multi-center study (2020) Westphalen CB, Kukiolka T, Garlipp B, Hahn L, Fuchs M, Malfertheiner P, Reiser M, et al. Journal article Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma (2020) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Göppinger S, Schwamborn K, Hieke-Schulz S, et al. Journal article IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. (2019) Langer V, Vivi E, Regensburger D, Winkler T, Waldner M, Rath T, Schmid B, et al. Journal article